ClinicalTrials.govpublic full text
ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer
metastatic prostate cancer, adc, antibody drug conjugate, prostate neoplasia, metastatic castration-resistant prostate cancer, psma, prostate specific membrane antigen, psma adc, prostate cancer, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 906761
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.